当前位置: 首页 > 详情页

Erythropoietin attenuates 6-hydroxydopamine-induced apoptosis via glycogen synthase kinase 3 beta-mediated mitochondrial translocation of Bax in PC12 cells

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Neurology, Second Affiliated Hospital of Soochow University, and Institute of Neuroscience, Soochow University, 1055 Sanxiang Road, Suzhou 215004, Jiangsu Province, China [2]Department of Neurology, First People’s Hospital of Xuzhou, Xuzhou 221002, China [3]Soochow University Affiliated Children’s Hospital, Suzhou 215003, China [4]Department of Neurology, Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China [5]Department of Anatomy, Nantong Medical College, Nantong 226001, China
出处:
ISSN:

关键词: Glycogen synthase kinase 3 beta 6-Hydroxydopamine Erythropoietin Parkinson's disease Bax

摘要:
The aim of this study was to determine the mechanism by which erythropoietin (EPO) suppressed 6-hydroxydopamine (6-OHDA)-induced apoptosis. Our results showed that 6-OHDA remarkably decreased phosphorylation of glycogen synthase kinase 3 beta (GSK3 beta) as well as enhanced the level of Bax in the mitochondria. Besides, 6-OHDA decreased the mitochondrial expression of Bcl-2 without altering the cytoplasmic expression of Bcl-2. In line with these results, 6-OHDA treatment enhanced the apoptosis and caspase 3 activity in PC12 cells. These findings indicated that mitochondrial dysfunction was involved in the neurotoxicity of 6-OHDA and GSK3 beta might act upstream of Bax/Bcl-2 and the caspase 3 pathways in 6-OHDA-treated PC12 cells. Furthermore, EPO reduced 6-OHDA-induced growth inhibition. Western blot exhibited that GSK3 beta inhibitor 4-benzyl-2-methyl-1, 2,4-thiadiazolidine-3, 5-dione (TDZD8) and EPO not only increased the phosphorylation of GSK3 beta but also inhibited the mitochondrial translocation of Bax. In agreement with these results, EPO and TDZD8 obviously increased the mitochondrial expression of Bcl-2. Finally, TDZD-8 and EPO significantly suppressed the enhanced apoptosis and activity of caspase 3 induced by 6-OHDA. Taken together, GSK3 beta-mediated mitochondrial cell death pathway is involved in the neuroprotective effect of EPO against 6-OHDA-induced apoptosis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2011]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学 4 区 神经科学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学 4 区 神经科学
JCR分区:
出版当年[2010]版:
Q3 CLINICAL NEUROLOGY Q4 NEUROSCIENCES
最新[2023]版:
Q2 CLINICAL NEUROLOGY Q3 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2010版] 出版当年五年平均 出版前一年[2009版] 出版后一年[2011版]

第一作者:
第一作者机构: [1]Department of Neurology, Second Affiliated Hospital of Soochow University, and Institute of Neuroscience, Soochow University, 1055 Sanxiang Road, Suzhou 215004, Jiangsu Province, China [2]Department of Neurology, First People’s Hospital of Xuzhou, Xuzhou 221002, China
通讯作者:
通讯机构: [1]Department of Neurology, Second Affiliated Hospital of Soochow University, and Institute of Neuroscience, Soochow University, 1055 Sanxiang Road, Suzhou 215004, Jiangsu Province, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院